Standard BioTools
Stock Forecast, Prediction & Price Target
Standard BioTools Financial Estimates
Standard BioTools Revenue Estimates
Standard BioTools EBITDA Estimates
Standard BioTools Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $130.58M N/A | $97.94M -24.99% | $106.34M 8.56% | Avg: $232.4M Low: $228.27M High: $236.52M avg. 118.54% | Avg: $277.6M Low: $273.71M High: $280.84M avg. 19.44% | Avg: $311.3M Low: $306.94M High: $314.93M avg. 12.13% | |
Net Income
% change YoY
| $-59.23M N/A | $-190.09M -220.91% | $-74.65M 60.72% | Avg: $-64.4M Low: $-13.66M High: $-13.21M avg. 13.73% | Avg: $9M Low: $1.55M High: $1.60M avg. 113.97% | Avg: $-1.58M Low: $-1.60M High: $-1.55M avg. -117.59% | |
EBITDA
% change YoY
| $-44.25M N/A | $-113.48M -156.43% | $-54.45M 52.01% | Avg: $-108.51M Low: $-110.43M High: $-106.58M avg. -99.26% | Avg: $-129.61M Low: $-131.12M High: $-127.80M avg. -19.44% | Avg: $-145.35M Low: $-147.04M High: $-143.31M avg. -12.13% | |
EPS
% change YoY
| -$0.78 N/A | -$2.43 -211.53% | -$0.94 61.31% | Avg: -$0.17 Low: -$0.17 High: -$0.17 avg. 81.91% | Avg: $0.02 Low: $0.02 High: $0.02 avg. 111.76% | Avg: -$0.02 Low: -$0.02 High: -$0.02 avg. -200% | |
Operating Expenses
% change YoY
| $136.83M N/A | $153.25M 12.00% | $113.48M -25.94% | Avg: $194.34M Low: $190.90M High: $197.79M avg. 71.24% | Avg: $232.14M Low: $228.89M High: $234.85M avg. 19.44% | Avg: $260.33M Low: $256.68M High: $263.36M avg. 12.13% | |
FAQ
What is Standard BioTools stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 3.37% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is -13.66M, average is -64.4M and high is -13.21M.
What is Standard BioTools stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 50.04% in 2025-2027.
We have gathered data from 2 analysts. Their low revenue estimate is $228.27M, average is $232.4M and high is $236.52M.
What is Standard BioTools stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -2.10% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.17, average is -$0.17 and high is $-0.16.
What is the best performing analyst?
In the last twelve months analysts have been covering Standard BioTools stock. The most successful analyst is Matthew Stanton.